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Introduction. The Centers for Disease Control and Prevention (CDC)’s National Tuberculosis Surveillance System (NTSS) is the
national repository of tuberculosis (TB) data in the United States. Jurisdictions report to NTSS through the Report of Veriﬁed
Case of Tuberculosis (RVCT) form that transitioned to a web-based system in 2009. Materials and Methods.T oi m p r o v eR V C T
data quality, CDC conducted a quality assurance (QA) needs assessment to develop QA strategies. These include QA components
(case detection, data accuracy, completeness, timeliness, data security, and conﬁdentiality); sample tools such as National TB
Indicators Project (NTIP) to identify TB case reporting discrepancies; comprehensive training course; resource guide and toolkit.
Results and Discussion. During July–September 2011, 73 staﬀ from 34 (57%) of 60 reporting jurisdictions participated in QA
training. Participants stated usefulness of sharing jurisdictions’ QA methods; 66 (93%) wrote that the QA tools will be eﬀective for
their activities. Several jurisdictions reported implementation of QA tools pertinent to their programs. Data showed >8% increase
in NTSS and NTIP enrollment through Secure Access Management Services, which monitors system usage, from August 2011–
February 2012. Conclusions. Despite challenges imposed by web-based surveillance systems, QA strategies can be developed with
innovation and collaboration. These strategies can also be used by other disease programs to ensure high data quality.
1.Introduction
In2010,therewere8.8millionnewcasesoftuberculosis(TB)
disease reported worldwide, with over 1 million TB deaths
[1].IntheUnitedStates,11,182peoplewerenewlydiagnosed
with TB disease [2]. The mission of the Division of Tubercu-
losis Elimination (DTBE), Centers for Disease Control and
Prevention (CDC) is to promote health and quality of life by
preventing, controlling, and eventually eliminating TB from
the United States, and by collaborating with other countries
and international partners in controlling TB globally [3].
Tuberculosis surveillance is a core public health function.
Ongoing and systematic collection, analysis, interpretation,
and dissemination of surveillance data allow programs to
target control interventions that provide the most impact in
eliminating TB [4]. These surveillance data are essential in
describingmorbidityandmortality,monitoringtrendsinTB
incidence and prevalence, detecting potential outbreaks, and
deﬁning high-risk groups. In addition, TB data are needed
to evaluate TB control programs, identify deﬁciencies, and
allocateresources.Inorderto performthese important func-
tions, it is essential that surveillance data are collected and
reported in an accurate, complete, and timely manner.
The CDC’s National Tuberculosis Surveillance System
(NTSS) is the national repository of TB surveillance data in
the United States. CDC receives data on TB cases from re-
porting jurisdictions through a standardized data collection
form, the Report of Veriﬁed Case of Tuberculosis (RVCT).
NTSS has 60 reporting jurisdictions: all 50 US states, the
District of Columbia, New York City, American Samoa, Fed-
erated States of Micronesia, Guam, Republic of the Marshall
Islands, Commonwealth of the Northern Mariana Islands,
Puerto Rico, Republic of Palau, and US Virgin Islands.
The RVCT was revised by a group of TB experts in 2009
and transitioned into a new web-based reporting system.
An interdisciplinary CDC DTBE team collaborated with key2 Tuberculosis Research and Treatment
national partners, state-based medical or health oﬃcers, and
other local healthcare professionals to launch a national
training program on the new RVCT [5, 6]. Extensive reviews
of training materials enabled partners to provide feedback
for improvements on the instructions for each of the 49
RVCT items [7]. The team also developed a self-study
manual for participants that was used during facilitator-led
trainings [8]. The manual can also be used as self-study for
newTBstaﬀandasareferenceguide.Inaddition,afacilitator
manual was developed and used during training-of-trainers
courses to build RVCT training capacity throughout the
reporting jurisdictions [9].
Quality assurance (QA) is a critical part of any successful
surveillance system and is a continuous cycle of monitoring,
evaluating, and improving data quality [10, 11]. Prior to
2009, jurisdictions depended on a CDC disk operating sys-
tem (DOS) used for surveillance of TB data. This system
provided a series of validation reports to jurisdictions for
managing data. When CDC transitioned to a web-based
system in 2009, there was a need for a standardized QA
process that jurisdictions could adapt to their setting.
The team determined that a logical followup to the
RVCT trainings was to enhance the QA knowledge and skills
of TB surveillance staﬀ. Furthermore, the RVCT training
participants expressed concerns regarding the lack of data
validationofsomestatesystemsandtheinabilityofreporting
areas to transmit all data electronically. DTBE staﬀ began
working individually with state public health partners to
develop QA strategies. This paper describes these strategies
to ensure the quality of TB data reported to the CDC’s NTSS
through the new web-based system.
2.MaterialsandMethods
The RVCT QA training team, in collaboration with key part-
ners, developed innovative strategies to provide standardized
methodologies, skills, and tools to enhance the capacity for
conducting QA. Similar to the RVCT training course, the
team used the systematic process for health education to
develop these QA strategies [6, 12]. This process includes
needs assessment, development, pilot testing, implementa-
tion, and outcome evaluation.
2.1. Quality Assurance Needs Assessment. During 2010-2011,
the training team conducted a comprehensive needs assess-
ment to determine strategies that could enhance QA for TB
surveillance data. During the needs assessment, the team
facilitated discussions of QA topics with prepared open-
ended questions to jurisdictions and CDC staﬀ.
The needs assessment included the following.
(i) meeting with TB program area staﬀ from 11 report-
ing jurisdictions in either focus groups or individual
interviews. Three incidence levels of TB-burden areas
were represented including low (≤3.5 cases per
100,000 population in 2009), medium (3.6–3.8 cases
per 100,000 population in 2009), and high TB inci-
dence (>3.8 cases per 100,000 population in 2009).
The staﬀ described their surveillance system, and
staﬀcharacteristics(trainingandexpertiselevel),and
shared their QA process and tools (i.e., tables, charts,
graphs, processes, and templates). Staﬀ suggested
content topics and prioritized QA components that
should be covered in the materials and a training
course. In addition, they discussed successes and
challenges experienced when conducting QA at their
sites;
(ii) meeting with colleagues from DTBE who have a role
in ensuring quality data including the subject matter
experts in the laboratory, the Data Management and
Statistics Branch, project oﬃcers for the National TB
Indicators Project (NTIP), and the TB Genotyping
Information Management System [13, 14]. These
staﬀ members collaborated to help develop and
conduct a comprehensive training program and QA
tools;
(iii) meeting with surveillance staﬀ from other CDC
divisions including the Division of STD Prevention,
Division of Viral Hepatitis, and the Division of HIV/
AIDS Prevention. Some of these colleagues indicated
they conducted QA only after data arrived at CDC.
None of the QA procedures or processes utilized by
other divisions met the needs of DTBE;
(iv) conducting a review of available QA materials on
surveillance data [15–38]. This review yielded infor-
mation on various QA components and deﬁnitions
(Table 1). However, the team did not ﬁnd a com-
prehensive QA framework, practical step-by-step
QA strategies for TB surveillance data, or practical
models for a QA training course;
(v) reviewing the surveillance section of the Tuberculosis
Elimination and Laboratory Cooperative Agreement,
a portion of an agreement between DTBE and NTSS
reporting jurisdictions that describes area surveil-
lance activities [39]. This yielded QA components
and a requirement to monitor data quality (Table 1).
2.2. Quality Assurance Strategies. The results of the needs
assessment were used to develop 4 strategies for enhancing
QA procedures in reporting jurisdictions. These include the
following.
(1)ProvidingaQAProcessThatIncludesFiveComponentsand
Categorizing Activities into Each of These Components. QA
components include case detection, data accuracy, data com-
pleteness,datatimeliness,anddatasecurityandconﬁdential-
ity. These components provided logical steps for conducting
QA activities and were designed to allow reporting areas to
utilize those strategies that would beneﬁt them.
(2) Providing QA Tools Including Guidance for a Written QA
Protocol. The RVCT QA training team provided a template
for a written QA protocol and other tools that jurisdictions
can easily adapt and use to conduct QA. Staﬀ from CDC and
the various jurisdictions developed over 45 tools that were
classiﬁed into each of the ﬁve QA components (Table 2). TheTuberculosis Research and Treatment 3
Table 1: Guidance∗ for developing a written protocol for quality assurance for tuberculosis surveillance data, United States, 2011.
(a) Case detection: Case detection is the discovery of the existence of a single instance of a speciﬁc disease or exposure, for example, tuberculosis (TB). This is
a front-line surveillance activity and typically accomplished as a by-product of routine medical or veterinary care, laboratory work, or via an astute observer.
The primary purpose is to ﬁnd all patients with TB diagnosis to treat and prevent TB transmission and are reported to the TB surveillance system
Activities Description Data sources
Maintain a registry of
TB cases.
Contains at a minimum the elements to produce data for the
national TB case report, the revised Report of Veriﬁed Case of
Tuberculosis (RVCT).
All local jurisdictions should also have at least a log, if not a
registry, that contains key demographic and clinical information
on each reported TB suspect.
Data on TB cases receiving diagnostic, treatment, or contact
investigation services in the local jurisdiction, although not
included in the annual morbidity total, should be included in the
TB registry.
(i) TB suspect registries from all
local jurisdictions.
Establish liaisons with
appropriate reporting
sources to enhance
quality assurance (QA)
of TB surveillance data.
Enhance identiﬁcation, reporting, and followup of TB cases and
suspects by establishing liaisons with appropriate reporting
sources.
Jurisdictions should provide a plan for case ﬁnding and how they
will or have established appropriate liaisons.
Thereafter, TB programs should provide periodic feedback and at
minimum, an annual written report summarizing surveillance
data to reporting sources.
(i) Hospitals.
(ii) Clinics (e.g., TB and HIV/AIDS
clinics).
(iii) Laboratories performing tests
for mycobacteria.
(iv) Selected physicians (e.g.,
pulmonary and infectious disease
subspecialists).
(v) Correctional facilities.
(vi) Community and migrant
health centers.
(vii) Pharmacies.
(viii) Other public and private
facilities providing care to
populations with or at risk for TB.
Develop and implement
active case detection
activities.
At a minimum, ongoing active laboratory surveillance should be
conducted by on-site visits in all areas to ensure complete
reporting of all TB cases and suspects with positive acid-fast bacilli
(AFB) smears and cultures for M. tuberculosis.
(i) Laboratory reports.
Evaluate the
completeness of
reporting of TB cases to
the surveillance system.
Periodically (e.g., at least every two years) evaluate the
completeness of reporting of TB cases to the surveillance system by
identifying and investigating at least one population-based
secondary data source to ﬁnd potentially unreported TB cases.
Secondary data source, for example
(i) statewide laboratory record
review,
(ii) pharmacy review,
(iii) hospital discharge data review,
Potential TB cases identiﬁed during the evaluation must be
veriﬁed.
(i) medical records,
(ii) physician, interviews,
(iii) patient interviews.
Reasons for nonreporting of TB cases should be determined and a
plan for improvement developed and implemented.
(b) Data accuracy: Data accuracy means that the data recorded match exactly what happens in a clinical encounter, whether or not it is clinically appropriate.
The primary purpose is to identify and correct errors in the surveillance data
Activities Description Data sources
Evaluate
accuracy/validity of
RVCT data.
At least annually evaluate the accuracy/validity of RVCT data by
comparing RVCT data and the jurisdiction’s TB registry data to
original data sources.
(i) RVCT data collection form.
(ii) Patients’ medical records.
(iii) TB registry database.
Assess knowledge, skills,
and abilities of staﬀ and
provide training if
needed.
Assess the knowledge, skills, and abilities of all existing personnel
and new hires whose duties involve the collection and reporting of
registry and RVCT data.
(i) Personnel ﬁles.
(ii) Staﬀ interviews.
(iii) Observations and evaluations
of staﬀ skills. Provide training and evaluation. Training will focus on accurate
and timely completion of the revised RVCT. All existing staﬀ will
be trained on the revised RVCT data collection, and new staﬀ
should be trained within 2 months of hire date.4 Tuberculosis Research and Treatment
(c) Data completeness: Data completeness means that the information submitted contains the mandatory set of data items. The primary purpose is to capture
all the relevant data on TB patients on the RVCT to support and improve the function of the TB surveillance system
Activities Description Data sources
Maintain completeness
for all RVCT variables.
TB case data will be reported to CDC using the revised RVCT form
via an electronic format that conforms to Public Health
Information Network (PHIN) and/or National Electronic Disease
Surveillance System (NEDSS) messaging standards.
(i) RVCT form via an electronic
format.
HIV status will be reported for at least 95 percent of all newly
reported TB cases, age 25–44 years. (i) HIV reports.
A valid genotype accession number (generated by the
CDC-sponsored genotyping laboratory) will be reported for at
least 85 percent of all reported culture-positive cases. (i) Genotyping reports.
TB programs will maintain at least 95 percent reporting
completeness for all variables existing on the pre-2009 RVCT. (i) Pre-2009 RVCT form.
By 2013, TB programs will achieve 95% completeness of all
variables in the revised RVCT. (i) Post-2009 RVCT form.
Match TB and AIDS
registries.
Collaborate with the HIV/AIDS program to conduct at least
annual TB and AIDS registry matches to ensure completeness of
reporting of HIV and TB coinfected patients to both surveillance
systems.
Investigate and verify all TB cases reported to the HIV/AIDS
program and not reported to the TB program. Update the TB
registry and report to CDC as needed.
At least annually assess reasons for incomplete HIV results on the
R V C Tf o re a c hv e r i ﬁ e dc a s eo fT B .
(i) TB registries.
(ii) HIV/AIDS registries.
Determine if patients were not tested for HIV or were tested but
results not reported to the TB program.
Develop and implement plans for improvement in increasing HIV
testing and reporting to patients and TB programs.
(d) Data timeliness: Data timeliness is the speed between steps in the surveillance system. Data are current and available on time. The primary purposei st o
ensure that data are available for TB program planning and for appropriate distribution of resources
Activities Description Data source
Report all newly
d i a g n o s e dc a s e so fT Bt o
the CDC according to
schedule.
Report all newly diagnosed cases of TB to the CDC according to a
schedule agreed upon each year, generally monthly, and at least
quarterly.
(i) RVCT reports.
Submit complete RVCT
reports according to
schedule.
The initial case reports should be submitted generally monthly and
at least quarterly.
(i) RVCT report.
(ii) Initial case report.
Followup 1 report, which is only for TB cases with positive culture
results, should be completed and submitted within 2 months after
the initial RVCT was submitted, or when drug susceptibility results
are available, whichever is later.
(i) RVCT reports.
(ii) Followup 1 (Initial Drug
Susceptibility Report).
The followup 2 report, which should be submitted for all cases in
which the patient was alive at diagnosis, should have data entered
as it becomes available, and it should be complete when the case is
closed to supervision. All followup 2 reports should be completed
within two years of initial case reporting.
(i) RVCT reports.
(ii) Followup 2 (Case Completion
Report).
Analyze TB surveillance
data at least quarterly.
At least quarterly, analyze TB surveillance data to monitor trends,
detect potential outbreaks, and deﬁne high-risk groups. Produce
and disseminate at least an annual report summarizing current
data and trends.
(i) Surveillance data base.
Evaluate programmatic
performance by using
TB surveillance data at
least annually.
At least annually, evaluate programmatic performance by using TB
surveillance data to assist in compiling supporting evidence to
determine the extent to which program objectives are being met
and also to assist in developing strategies for improvement.
(i) National TB Indicators Project
reports.Tuberculosis Research and Treatment 5
(e) Data security and conﬁdentiality: Data security is the protection of public health data and information systems against unauthorized access. Data
conﬁdentiality is the protection of personal information collected by public health organizations. The primary purpose of security is to prevent unauthorized
release of identifyinginformation and accidental data loss or damage to the systems, while conﬁdentiality is to ensure that personal information is notreleased
without the consent of the person involved, except as necessary to protect public health
Activities Description Data sources
Ensure that TB
surveillance data are
kept conﬁdentially and
that all data ﬁles are
secure.
Policies and procedures must be in place to protect the
conﬁdentiality of all surveillance case reports and ﬁles.
(i) Data security and conﬁdentiality
policies and procedures of the TB
program.
(ii) Surveillance case reports and
ﬁles.
Policies and procedures to protect HIV test results must conform
to the conﬁdentiality requirements of the state and local
HIV/AIDS programs.
(i) Conﬁdentiality requirements of
the state and local HIV/AIDS
programs.
(ii) Observation of staﬀ.
Provide training on security and conﬁdentiality of data.
∗Adopted from the 2011 cooperative agreement between the Division of Tuberculosis Elimination, Centers for Disease Control and Prevention and all 60
reporting jurisdictions of the National Tuberculosis Surveillance System.
tools include tables, charts, graphs, processes, and templates
and are available in common electronic formats (e.g., Word,
Excel, and PowerPoint). The team developed a main tool
which is a template to help jurisdictions write a QA protocol
required in the annual DTBE Cooperative Agreement (Table
2).
The National Tuberculosis Indicators Project (NTIP) is
also an important QA tool [13]. During 2010, an NTIP
module was developed to allow users to identify any TB
case reporting discrepancies. This module has proven useful
in recognizing data coding errors and data transmission
problems,andhighlightingtheissuethaterrorsareoccurring
more frequently than was previously recognized.
The reporting jurisdictions can access their NTIP and
NTSS QA reports such as the missing and unknown
(MUNK) reports through the Secure Access Management
Services (SAMS). SAMS is a federal information technology
systemthatgivesauthorizedpersonnelsecure,externalaccess
to nonpublic CDC applications.
(3) Developing and Conducting a QA Training Course. The
trainingteamdevelopedandconductedacomprehensiveQA
training course to enhance the knowledge and skills needed
by TB surveillance staﬀ from the reporting jurisdictions for
conducting QA. The results of the needs assessment and
collaboration with subject matter experts were key to devel-
opment of the QA course. The course focused on the QA
process and ﬁve components, as well as other related topics
to increase course participants’ use of NTSS data for QA and
program planning.
The course format included presentations from faculty
(DTBE subject matter experts) with slides and handouts, ex-
ercises to apply the content to realistic situations, interactive
discussions to share experiences and answer questions, and
tools to use or adapt to their setting. Participants also de-
scribed how they conducted QA at their sites and provided
examples of QA challenges they encounter.
(4) Developing a Resource Guide and Toolkit. The training
teamiscurrentlydevelopingaresourceguideandtoolkitthat
can be used as a QA reference guide or a training manual. It
will include many of the materials developed for the course
such as handouts, exercises to apply the content, glossary,
and examples of the tools (Table 2). A companion CD will
provide the tools in easy-to-use formats (Word, Excel, and
PowerPoint) so that jurisdictions can adapt them to their
ownsetting.Theguideandtoolkitwillbeavailableinaprint-
based format with a companion CD that includes the tools.
In addition, the materials will be downloadable from the
CDC website.
3. Results and Discussion
3.1. Quality AssuranceTrainingEvaluations. In July 2011, the
team facilitated a pilot test of the 2-day QA training course
with eleven TB surveillance experts from various state and
local TB programs. The participants provided suggestions
on how to improve the materials, the presentations, and
the course schedule. The comprehensive course evaluation
included written evaluations with qualitative and quantita-
tive questions; discussions at the end of each of the ﬁve QA
components; an end-of-course written evaluation; observa-
tions by course faculty. The team revised the materials and
training course based on the analysis of the evaluation results
(Table 3).
Theteamandotherfacultymembersalsoconductedfour
2-day trainings in Atlanta, GA, between August and Septem-
ber 2011. Course participants included 61 TB surveillance
staﬀ. Participants from the four trainings completed an end-
of-courseevaluationformconsistingofqualitativeandquan-
titative questions.
Results of the combined responses from the pilot course
and four trainings evaluations (Table 3) indicated that par-
ticipants learned about the QA process and beneﬁted from
sharing information on how other jurisdictions implement
the QA components at their sites. The 73 participants (from
the pilot course and four trainings) represented 34 (57%)
of the 60 NTSS reporting jurisdictions. The 34 jurisdictions
represent more than 80% of all TB cases reported to CDC
each year.6 Tuberculosis Research and Treatment
Table 2: Master list of quality assurance tools for TB surveillance, United States, 2011.
(a) Quality assurance protocol tools
Tool number Tool name Description and how to use Format
QA protocol-1 Cooperative agreement The original version of the TB surveillance section of the
cooperative agreement. PDF
QA protocol-2 QA written
protocol-requirements
A table that lists all of the cooperative agreement
requirements for TB surveillance and sources for
information.
Word
QA protocol-3 QA written protocol-guide A guide to help jurisdictions write their own protocol. Word
(b) Case detection tools
Tool number Tool name Description and how to use Format
Case detection-1 TB program area module
(TB PAM) ﬂow chart
Flow chart to help with patient search. This ﬂow chart
was created initially to emphasize the importance of
always searching for a patient within TB PAM so that
duplicate patient records are not created. This ﬂow chart
also outlines the process for creating “Provider Veriﬁed”
cases and addresses approval and rejection of
notiﬁcation.
Word
Case detection-2 Notiﬁcation process
Flow chart that shows a tiered notiﬁcation process for TB
case notiﬁcation. This ﬂow chart identiﬁes (1) what role
each person (with a particular TB PAM right) has in the
notiﬁcation process and what happens when a
notiﬁcation is rejected or approved. Only TB program
managers (a nurse within the TB program) creates a
notiﬁcation, and it must be approved by the TB Program
Central Oﬃce Epidemiologist before it is sent to CDC
for case counting.
Word
Case detection-3 TB suspects weekly report
This report is generated weekly for all suspects reported
in TB PAM through Friday of the previous week.
Suspects are classiﬁed as a case or not a case within 56
days from the date of report. There is a built-in
calculation that calculates 56 days from the date of report
(when the date of report is entered). All suspects that are
past due (over 56 days) require a followup from one of
the Central Oﬃce Nurse Consultants.
Excel
Case detection-4 Case veriﬁcation and
treatment status
Table that indicates case veriﬁcation and treatment
status. This spreadsheet is used to monitor treatment
progress with the goal of completing treatment within 12
months. There are built-in calculations for 3, 6, 9, and 12
months from treatment start that are populated when
the date therapy started is entered. Case veriﬁcation is
included to help identify how long treatment is
anticipated for.
Excel
Case detection-5 Decline in reported
tuberculosis cases survey Sample survey to investigate decline in reported TB cases. Word
Case detection-6 Counted tuberculosis case
veriﬁcation report Form that indicates counted TB case veriﬁcation. PDF
Case detection-7 Investigation process for
underreporting of TB
Table that provides a process for investigating
underreporting of TB data. Word
Case detection-8a TB case closeout letter Sample letter to accompany TB case close list (tool 8b)
and TB case closeout form (tool 8c). Word
Case detection-8b TB case close list List by jurisdiction indicating TB case closeout status. Excel
Case detection-8c TB case closeout form Form for conﬁrmation/signature of number of TB cases. WordTuberculosis Research and Treatment 7
(c) Accuracy tools
Tool number Tool name Description and how to use Format
Accuracy-1a Data accuracy checklist A checklist for reviewing RVCT data for accuracy Word
Accuracy-1b Data accuracy checklist CDC
SAS code
SAS code corresponding to the data accuracy checklist,
accuracy tool-1a, and is based on CDC RVCT variable
names.
Word
Accuracy-1c CDC TB surveillance RVCT
data dictionary
Data dictionary for interpreting the CDC RVCT variable
names used in data accuracy checklist CDC SAS code,
accuracy tool-1b
Excel
Accuracy-2
Options for prioritizing
medical chart reviews when
resources are limited
Various options to help prioritize medical chart reviews
when resources are limited. Word
Accuracy-3 RVCT surveillance database
audit form Checklist for checking the accuracy of RVCT. Word
Accuracy-4 Accuracy checklist for
sputum culture conversion
Table to indicate number of days for culture conversion by
jurisdiction. This applies to cases that are sputum culture
positive only. There are built-in calculations that calculate
the date, that is, 30 and 60 days from treatment start (once
the date therapy started is entered). There is also a built-in
calculation for the number of days that it took for sputum
culture conversion. This helps identify those patients who
did not meet the National Tuberculosis Indicators Project
(NTIP) Objective of converting their sputum culture within
60 days of treatment initiation.
Excel
Accuracy-5 Nucleic acid ampliﬁcation
test (NAAT) comparisons Comparison of NAAT tests. Excel
Accuracy-6 RVCT calculated variables RVCT calculated variables algorithm for calculating vercrit. Word
Accuracy-7
2009 RVCT form with public
health information network
(PHIN) variable
identiﬁcation
2009 RVCT form with PHIN variable identiﬁcation by
RVCT question number to use as a reference for report
codes.
PDF
(d) Completeness tools
Tool number Tool name Description and how to use Format
Completeness-1 Source list for locating RVCT
data
Source document to locate information for each item on
the RVCT. Word
Completeness-2 Therapy status
Table to indicate therapy status by 12-month interval. This
spreadsheet is used to monitor treatment progress with
the goal of completing treatment within 12 months. There
are built-in calculations for 3, 6, 9, and 12 months from
treatment start that are populated when the date therapy
started is entered. This tool targets the NTIP objective of
treatment completion within 12 months.
Excel
Completeness-3 Culture and drug
susceptibility status
Table to indicate culture and drug susceptibility status by
jurisdiction. This report shows the susceptibility results
for isoniazid, rifampin, pyrazinamide, and ethambutol.
This shows those cases that are multidrug-resistant TB and
also those who have an unknown or blank susceptibility
report. This is for all culture-positive TB cases. This tool
targets the NTIP objective of drug susceptibility reporting.
Excel
Completeness-4 TB Program area module
(TB PAM)
Flow chart that shows the TB PAM process (initiation of
RVCT through case closure). This ﬂow chart was created
for the TB PAM from initiating the RVCT to closing a
case. This ﬂow chart also identiﬁes the responsible
person(s) for the various steps.
Word
Completeness-5 Data abstraction instructions Detailed procedures for RVCT quality control queries. Word
Completeness-6a RVCT variables used in
NTIP
List of the RVCT variables used in the NTIP indicator
calculation. PDF
Completeness-6b RVCT variables used in
NTIP spreadsheet
Spreadsheet of the list of the RVCT variables used in the
NTIP indicator calculation. Excel8 Tuberculosis Research and Treatment
(e) Timeliness tools
Tool number Tool name Description and how to use Format
Timeliness-1a Building blocks—schedule
for entering RVCT data
Timeline table. This is a building-block diagram
addressing what RVCT variables should be entered and
identiﬁes the time frame when those variables should be
entered. This helps ﬁeld staﬀ know when information
should be available and when the state central oﬃce
expects it to be entered.
Word
Timeliness-1b Schedule for entering RVCT
data
Timeline table similar to timeliness tool 1a. It is in a table
format rather than the graphic of the building blocks. Word
Timeliness-2 Quarterly case summary
Document that summarizes timeliness measures and
objectives for a predetermined set of TB patients.
Predeﬁned case outcome objectives are presented for that
particular set of TB patients.
Excel
Timeliness-3 Timeliness data dictionary
Description of the data used to calculate timeliness
measures for analysis. These measures are used to
determine completion of state objectives.
Word
Timeliness-4 2010 Final verbal case counts
and data submissions Spreadsheet for case count. Excel
Timeliness-5 Timeline for reporting TB
data to CDC
Timeline for reporting TB cases and ﬁnal TB data
transmissions to CDC. PDF
Timeliness-6 Typical weekly data
availability chart Typical weekly data availability by day of the week. PDF
(f) Data security and conﬁdentiality tools
Tool number Tool name Description and how to use Format
Data security and
conﬁdentiality-1
Standards for data security
and conﬁdentiality
List of minimum standards to facilitate data sharing and
use of surveillance data for public health action. Word
Data security and
conﬁdentiality-2
Initial assessment of TB
program data security and
conﬁdentiality
Guide for the initial assessment of TB program’s data
security and conﬁdentiality. Word
Data security and
conﬁdentiality-3
Checklist for ongoing
assessment of programs
Comprehensive checklist for assessing data security and
conﬁdentiality. Word
Data security and
conﬁdentiality-4
Data security and QA
checklist A TB program’s checklist for data security and QA. Word
(g) Other tools
Tool number Tool name Description and How to Use Format
Other-1 QA protocol example Four-phase process for entering RVCT data, to conduct
quality control, and ensure timeliness in reporting. Word
Other-2 QA in surveillance literature
sources References for quality assurance of surveillance data. Word
Other-3 2009 trending guidance
Mapping the old RVCT data to the new RVCT data and
diagrams to illustrate the following three RVCT items:
(i) 16—site of disease,
(ii) 22A—X-ray,
(iii) 46—type of health care provider.
This document provides a visual explanation of the
transition between old and revised RVCT variables.
Mapping shows the user exactly how the deﬁnitions of
previous variables match up with the new ones.
Word
Other-4 Cohort review preparation
Timeline for planning and conducting a cohort review
session. Includes preparation timeline and job
responsibilities. Determines when participants need to be
notiﬁed of scheduled events leading up to the cohort
review session.
Word
Other-5 TB case/suspect QA review
form A checklist to use when reviewing TB cases/suspects. Word
Other-6 TB review and QA schedule Quality assurance schedule for various reviews of TB
cases/suspects. WordTuberculosis Research and Treatment 9
Table 3: Combined evaluation resultsof thequality assurancetraining courses, Centers for Disease Controland Prevention, July–September
2011.
Evaluation question
Combined responses from the pilot course and four trainings
Reponses N = 73 Participants’ comments
Overall, how conﬁdent are you
that the target audience can learn
about QA after having attended
this course?
Very conﬁdent/conﬁdent 99% (72)
“Great job! Please continue this class. It was
very informative and I learned a lot.”
“Identiﬁed a number of good suggestions on
how to improve my states level of accuracy
with new tools provided by diﬀerent topic
speakers.”
How eﬀective will the QA process
(as described in this course) help
you conduct QA in your job?
Very eﬀective/eﬀective 100% (73)
“I learned a great deal from this pilot. This
course will be valuable to the states and will
lead to great discussions and changes in the
way QA is performed. This will therefore lead
to great improvement in the quality of the
data.”
How eﬀective will the tools be in
helping you conduct QA in your
job?
Very eﬀective/eﬀective 93% (66)
“Very informative—lots of info I can actually
use and apply to day-to-day activities (i.e.,
tools)”
Of the 73 participants, 66 (93%) stated that the QA tools
will be eﬀective in helping them conduct QA in their pro-
grams (Table 3). Participants stated that some of the most
important things they learned were the ﬁve QA components
and how they relate to the requirements in the cooperative
agreementforawrittenQATBsurveillanceprotocol.Mostof
the participants appreciated the assessment of programmatic
needs and the eﬀort that went into implementing the course.
3.2. Quality Assurance Strategies with Limited Resources. In
developing innovative strategies for QA of TB surveillance
data, a key question for all programs is how best to maximize
theuseoflimitedresourcestoensuredataquality.Thedesign
and ﬂexibility of the guide and toolkit enable health care
staﬀ to learn about the QA process in a self-study format or
as part of a facilitator-led training course. Also, providing
the materials in print-based format and the internet ensures
accessibility to the materials without additional resources.
Gaining knowledge and skills to conduct QA helps reporting
jurisdictions remain vigilant in maintaining high quality of
surveillance data despite limited resources.
3.3. Impact of Quality Assurance Strategies. This QA project
represents a signiﬁcant improvement to NTSS because it
compiles for the ﬁrst time guidelines, step-by-step process,
and tools for monitoring and improving the quality of TB
surveillance data. Additionally, CDC noticed an unprece-
dented timeliness and accuracy of all the required RVCT
variables needed for publication on TB surveillance data in
the Morbidity and Mortality Weekly Report issue for the
World TB Day on March 24, 2012. The process to obtain
data has been much easier than previous years because of
improved understanding between CDC and jurisdictions
fostered at the QA training.
Although the team conducted training on the QA strat-
egies less than a year ago, CDC staﬀ have also noticed better
collaborationamongNTSSreportingjurisdictionsinsharing
QA tools. Several jurisdictions sent letters to CDC shortly
after the training stating that they have implemented QA
tools that were pertinent to their programs.
In addition, SAMS portal reports indicated a 10% in-
crease of NTSS enrollment from August 2011 to February
2012 and an 8% increase of NTIP enrollment for the same
period. But it may be premature to attribute these results to
the QA strategies.
The team also attempted to obtain MUNK reports of the
jurisdictions represented during the QA training to examine
any QA improvement, but this information was not readily
available.ThisinformationcancompareRVCTdataandhow
missing or validation issues occur from the previous year.
However, this may not be a reliable measurement of the
impact of the QA strategies because the MUNK reports are
inﬂuenced by changes in the number of TB cases, complexity
of data-related issues, changes to state-based systems, or staﬀ
turnover.
The impact of the QA strategies to the quality of TB
surveillance data can be better evaluated after the jurisdic-
tions have fully implemented them. A survey of their QA
practicesmaysystematicallyevaluatetheimportanceofthese
strategies.
Despite the limitations, these QA strategies support TB
policies, laws, and regulations as they equip local jurisdic-
tions with a systematic set of processes and tools that may be
used to fulﬁll the requirements of the cooperative agreement
to monitor data quality. Also, since reporting of a patient
with TB disease to health authorities is mandated by state
laws, the guidance on case detection, data accuracy, com-
pleteness, and timeliness helps reporting areas in complying
with these laws.
In addition, these strategies are essential in collecting
accurate and reliable TB surveillance data that are critical to
making decisions to meet DTBE’s priorities: interrupt trans-
mission of Mycobacterium tuberculosis, reduce TB in foreign-
born populations, reduce TB in racial/ethnic minority pop-
ulations, mitigate/reduce impact of multidrug-resistant and
extensivelydrug-resistantTB,andreduceHIV-associatedTB.10 Tuberculosis Research and Treatment
Being vigilant in performing QA ensures high-quality data
and ultimately helps accelerate progress toward elimination
of TB in the United States.
4. Conclusions
Despite challenges imposed by various surveillance systems,
economic constraints, and new diagnostic technologies,
strategies for conducting QA can be developed with inno-
vation and collaboration. Mobilizing the TB community to
ensure high-quality data involves commitment, time, and
energy of TB leaders and partners.
Guidelines, a step-by-step process, and tools for moni-
toring and improving the quality of TB surveillance data are
essential for the TB community to eﬀectively control TB. Fu-
ture evaluation on the impact of these QA strategies will
further demonstrate their importance in maintaining data
quality.
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